237 filings
6-K
GLMD
Galmed Pharmaceuticals Ltd
5 Jun 24
Current report (foreign)
4:16pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
30 May 24
Current report (foreign)
4:30pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
19 Mar 24
Current report (foreign)
4:30pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
15 Mar 24
Current report (foreign)
9:13am
EFFECT
wl0il4ztmuzf2jmtnpf
30 Nov 23
Notice of effectiveness
12:15am
POS AM
m9p6 eg6klrhf6wif
22 Nov 23
Prospectus update (post-effective amendment)
4:48pm
6-K
qd4w4 n0yg354
22 Nov 23
Current report (foreign)
4:05pm
6-K
acmtv1 dzlx5
20 Nov 23
Galmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
4:37pm
POS AM
f6ldry dr4e
1 Nov 23
Prospectus update (post-effective amendment)
4:15pm
6-K
9fu 7dodxttligte0
26 Sep 23
Galmed Announces Allowance of New Patent for Aramchol for the Treatment of Pulmonary and Dermal Fibrosis
8:51am
6-K
291bi y2uyw3dl
22 Sep 23
Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification
4:15pm
6-K/A
vzsdr
21 Sep 23
Current report (foreign) (amended)
7:30am
6-K
vocudosuk5l9r
20 Sep 23
Current report (foreign)
4:30pm
6-K
1ha238
13 Sep 23
Current report (foreign)
4:01pm
6-K
kb26 xhkjhb0myr
9 Aug 23
Current report (foreign)
4:43pm
6-K
p2phf1soxf1woihrb21
9 Aug 23
Current report (foreign)
4:30pm
6-K
fuzc0u l3084
2 Aug 23
Consolidated Financial Statements
4:30pm
6-K
xm7v9itglz2g49 5so
18 Jul 23
Current report (foreign)
9:25am
424B4
u3p7w3 zbqndoi5x
18 Jul 23
Prospectus supplement with pricing info
9:23am